Related Experiment Video
Updated: Aug 7, 2026

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Ebp1 isoforms distinctively regulate cell survival and differentiation
Zhixue Liu1, Jee-Yin Ahn, Xia Liu
1Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA.
Abstract:
Ebp1, an ErbB3 receptor-binding protein, inhibits the proliferation and induces the differentiation of human cancer cells. Ebp1 binds nuclear Akt and prevents DNA fragmentation by inhibiting caspase-activated DNase. Here, we show that Ebp1 possesses two different isoforms, p48 and p42, which differentially mediate PC12 cell survival and differentiation. The longer-form p48 localizes in both the cytoplasm and the nucleus and suppresses apoptosis, whereas the shorter-form p42 predominantly resides in the cytoplasm and promotes cell differentiation. EGF strongly stimulates p42 to bind ErbB3, and the association depends on PKC-mediated phosphorylation of Ebp1. By contrast, p48 does not bind to ErbB3 regardless of EGF treatment. Overexpression of p48 provokes cell proliferation, which is inhibited by p42. Moreover, nerve growth factor elicits extensive sprouting in p42 stably transfected PC12 cells, whereas p48 cells reveal modest neurite outgrowth. Although mitogen-activated protein kinase cascade remains similar in both cells, Akt is more active in p48 cells than in p42 cells. Thus, Ebp1 might regulate cell survival and differentiation through two distinctive p48 and p42 isoforms.
Insights
ErbB3 receptor-binding protein 1 (Ebp1) has two isoforms, p48 and p42, that distinctly control cancer cell survival and differentiation. Ebp1 isoforms differentially regulate cell fate, offering new therapeutic targets.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- ErbB3 receptor-binding protein 1 (Ebp1) is known to inhibit cancer cell proliferation and induce differentiation.
- Ebp1 interacts with nuclear Akt, preventing DNA fragmentation by inhibiting caspase-activated DNase.
Purpose of the Study:
- To investigate the differential roles of Ebp1's two isoforms, p48 and p42, in mediating cell survival and differentiation.
- To explore the specific interactions and signaling pathways influenced by each Ebp1 isoform.
Main Methods:
- Utilized PC12 cell lines stably transfected with either p48 or p42 Ebp1 isoforms.
- Investigated protein localization, apoptosis suppression, cell differentiation, neurite outgrowth, and Akt/MAPK pathway activation.
- Examined epidermal growth factor (EGF) and nerve growth factor (NGF) mediated signaling.
Main Results:
- The longer p48 isoform suppresses apoptosis and promotes proliferation, localizing in both cytoplasm and nucleus.
- The shorter p42 isoform promotes differentiation and neurite outgrowth, primarily in the cytoplasm.
- EGF stimulates p42 binding to ErbB3 via PKC-mediated phosphorylation; p48 does not bind ErbB3.
- Akt activity is higher in p48 cells, while p42 cells exhibit more extensive NGF-induced neurite outgrowth.
Conclusions:
- Ebp1 isoforms p48 and p42 exhibit distinct functions in regulating cell survival and differentiation.
- Ebp1 isoform-specific signaling pathways, including Akt activation and ErbB3 binding, underlie their differential effects.
- These findings suggest Ebp1 isoforms as potential targets for cancer therapy, modulating cell fate decisions.
Related Concept Videos
Negative Regulator Molecules
Maintenance of the ES Cell State
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Abnormal Proliferation
Regulation of the Unfolded Protein Response
Master Transcription Regulators

